immune system
• regulatory T cells from CpG-treated mice fail to suppress ex vivo proliferation of A1 T cells and addition of PD1/PDL1 blocking antibodies fail to enhance A1 proliferation compared with wild-type cells
|
• reduced ear swelling, vascular leakiness and cytokine production (IL6, IFN-gamma and TNF) in a contact hypersensitivityreduced ear swelling, vascular leakiness and cytokine production (IL6, IFN-gamma and TNF) in a contact hypersensitivity assay with oxazolone assay with oxazolone
• however, swelling induced with a non-specific irritant (lactic acid) is normal
|
• attenuated chemotactic cytokine production in a contact hypersensitivity assay with oxazolone
• however, lymph node cells treated with PMA and ionomycin exhibit normal secretion
|
• in a contact hypersensitivity assay with oxazolone
• however, lymph node cells treated with PMA and ionomycin exhibit normal secretion
|
• in a contact hypersensitivity assay with oxazolone
• however, lymph node cells treated with PMA and ionomycin exhibit normal secretion
|
• in a contact hypersensitivity assay with oxazolone
• however, lymph node cells treated with PMA and ionomycin exhibit normal secretion
|
neoplasm
homeostasis/metabolism
N |
• mice exhibit normal basal serum kynurenine levels
|
hematopoietic system
N |
• mice exhibit normal hematopoiesis
|
• regulatory T cells from CpG-treated mice fail to suppress ex vivo proliferation of A1 T cells and addition of PD1/PDL1 blocking antibodies fail to enhance A1 proliferation compared with wild-type cells
|